|1.||Miura, Yoshikazu: 2 articles (09/2012 - 11/2006)|
|2.||Fickova, Maria: 1 article (06/2015)|
|3.||Macho, Ladislav: 1 article (06/2015)|
|4.||Brtko, Julius: 1 article (06/2015)|
|5.||Kubota, Keiichi: 1 article (09/2012)|
|6.||Kimura, Shinzo: 1 article (09/2012)|
|7.||Sawada, Tokihiko: 1 article (09/2012)|
|8.||Hori, Yuichi: 1 article (09/2012)|
|9.||Inoue, Kenichi: 1 article (09/2012)|
|10.||Sakurai, Yuichirou: 1 article (09/2012)|
03/01/1987 - "The relatively lipophilic compound, triphenyltin chloride, appeared to be anomalous because it did not readily promote hemolysis or induce the formation of intramembranous aggregates in human erythrocytes. "
03/01/1987 - "Organotin compounds examined in this study exhibited a relative order of potency for induction of in vitro hemolysis in human erythrocytes as follows: tri-n-butyltin greater than tri-n-propyltin greater than tetra-n-butyltin greater than triphenyltin chloride greater than tri-n-ethyltin bromide greater than dibutyltin dichloride greater than stannous chloride greater than tri-n-methyltin chloride = butyltin chloride dihydroxide. "
|2.||Body Weight (Weight, Body)
06/01/2006 - "Specimens of Bolinus brandaris (neogastropod) were injected with a single dose of 500 ng/g body weight (b.w.) of tributyltin chloride (TBTCl) or triphenyltin chloride (TPTCl), or a mixture of both compounds (250 ng TBT/g b.w.+250 ng TPT/g b.w.), for a period of up to 31 days. "
09/28/2012 - "Oral administration of triphenyltin chloride (TPT) (6 mg/100g body weight) inhibits insulin secretion by decreasing glucose-induced cytoplasmic Ca(2+) concentration ([Ca(2+)](i)) in pancreatic β-cells of the hamster. "
11/01/2006 - "Oral administration of triphenyltin chloride (TPT) (60 mg/kg body weight) inhibits the insulin secretion by decreasing the cytoplasmic Ca2+ concentration ([Ca2+]i) induced by glucose-dependent insulinotropic polypeptide (GIP) in pancreatic beta-cells of the hamster. "
01/01/1996 - "We performed an intravenous glucose tolerance test (IVGTT) after the administration of triphenyltin chloride (TPTCl-Ad) in hamsters in order to confirm the presence of glucose intolerance and to clarify the pathogenesis of TPTCl-induced glucose intolerance. "
01/01/1996 - "Triphenyltin chloride induces glucose intolerance by the suppression of insulin release from hamster pancreatic beta-cells."
11/30/1984 - "dose of 0.3-10 mg/kg of organotin compounds such as dibutyltin dichloride (Bu2SnCl2) and triphenyltin chloride (Ph3SnCl) on the development of edema after subplantar injection of 0.5 mg of carrageenan in 0.05 ml of pyrogen-free saline were examined as compared with those of hydrocortisone. "
|5.||Chromosome Aberrations (Chromosome Abnormalities)
03/01/1994 - "We previously reported that the organotin triphenyltin chloride (TPTC), which has been widely used as an anti-fouling coating for fishing nets and ship bottoms, potentiated clastogen-induced chromosome aberrations during the G2 phase of the cell cycle. "
03/01/1994 - "Antagonizing effect of triphenyltin chloride on cytosine-1-beta-D-arabinofuranoside potentiation of chromosome aberrations induced by mitomycin C."
|6.||stannous chloride (tin chloride)
|7.||9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)